Plasma biomarkers of brain atrophy in Alzheimer's disease.
Peripheral biomarkers of Alzheimer's disease (AD) reflecting early neuropathological change are critical to the development of treatments for this condition. The most widely used indicator of AD pathology in life at present is neuroimaging evidence of brain atrophy. We therefore performed a pro...
Saved in:
| Main Authors: | Madhav Thambisetty, Andrew Simmons, Abdul Hye, James Campbell, Eric Westman, Yi Zhang, Lars-Olof Wahlund, Anna Kinsey, Mirsada Causevic, Richard Killick, Iwona Kloszewska, Patrizia Mecocci, Hilkka Soininen, Magda Tsolaki, Bruno Vellas, Christian Spenger, Simon Lovestone, AddNeuroMed Consortium |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0028527&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting progression of Alzheimer's disease using ordinal regression.
by: Orla M Doyle, et al.
Published: (2014-01-01) -
Plasma based markers of [11C] PiB-PET brain amyloid burden.
by: Steven John Kiddle, et al.
Published: (2012-01-01) -
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis.
by: Petroula Proitsi, et al.
Published: (2014-09-01) -
A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease.
by: Wasim Khan, et al.
Published: (2015-01-01) -
Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets
by: Stephanie Evans, et al.
Published: (2019-01-01)